# Atmus Filtration Technologies Inc.: financial statements, quarterly ATMU · NYSE · CIK 1921963 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/atmu.md) · [Financials](/companies/atmu/financials.md) · [Filings](/companies/atmu/filings.md) · [Insiders](/companies/atmu/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atmu/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [396](/filings/0001921963-24-000118.md) | [400 d](/filings/0001921963-26-000015.md) | [427](/filings/0001921963-25-000075.md) | [433](/filings/0001921963-25-000121.md) | [404](/filings/0001921963-25-000134.md) | [407 d](/filings/0001921963-26-000015.md) | [417](/filings/0001921963-26-000042.md) | [454](/filings/0001921963-26-000069.md) | [448](/filings/0001921963-25-000134.md) | [447 d](/filings/0001921963-26-000015.md) | [478](/filings/0001921963-26-000042.md) | [528](/filings/0001921963-26-000069.md) | | Cost of revenue | $m | [293](/filings/0001921963-23-000025.md) | [294 d](/filings/0001921963-26-000015.md) | [315](/filings/0001921963-25-000075.md) | [301](/filings/0001921963-25-000121.md) | [292](/filings/0001921963-25-000134.md) | [300 d](/filings/0001921963-26-000015.md) | [306](/filings/0001921963-26-000042.md) | [323](/filings/0001921963-26-000069.md) | [318](/filings/0001921963-25-000134.md) | [319 d](/filings/0001921963-26-000015.md) | [341](/filings/0001921963-26-000042.md) | [374](/filings/0001921963-26-000069.md) | | Gross profit | $m | [103](/filings/0001921963-24-000118.md) | [106 d](/filings/0001921963-26-000015.md) | [112](/filings/0001921963-25-000075.md) | [132](/filings/0001921963-25-000121.md) | [111](/filings/0001921963-25-000134.md) | [107 d](/filings/0001921963-26-000015.md) | [111](/filings/0001921963-26-000042.md) | [131](/filings/0001921963-26-000069.md) | [129](/filings/0001921963-25-000134.md) | [127 d](/filings/0001921963-26-000015.md) | [137](/filings/0001921963-26-000042.md) | [154](/filings/0001921963-26-000069.md) | | Research and development | $m | [11.1](/filings/0001921963-24-000118.md) | [9.3 d](/filings/0001921963-26-000015.md) | [10.1](/filings/0001921963-25-000075.md) | [10.4](/filings/0001921963-25-000121.md) | [9.7](/filings/0001921963-25-000134.md) | [10.4 d](/filings/0001921963-26-000015.md) | [9.1](/filings/0001921963-26-000042.md) | [10.7](/filings/0001921963-26-000069.md) | [10.0](/filings/0001921963-25-000134.md) | [10.9 d](/filings/0001921963-26-000015.md) | [8.1](/filings/0001921963-26-000042.md) | [9.8](/filings/0001921963-26-000069.md) | | Selling, general and administrative | $m | [41.3](/filings/0001921963-24-000118.md) | [48.3 d](/filings/0001921963-26-000015.md) | [43.3](/filings/0001921963-25-000075.md) | [49.1](/filings/0001921963-25-000121.md) | [46.4](/filings/0001921963-25-000134.md) | [48.8 d](/filings/0001921963-26-000015.md) | [45.9](/filings/0001921963-26-000042.md) | [46.1](/filings/0001921963-26-000069.md) | [45.9](/filings/0001921963-25-000134.md) | [46.4 d](/filings/0001921963-26-000015.md) | [51.0](/filings/0001921963-26-000042.md) | [51.7](/filings/0001921963-26-000069.md) | | Operating income | $m | [58.8](/filings/0001921963-24-000118.md) | [56.2 d](/filings/0001921963-26-000015.md) | [68.6](/filings/0001921963-25-000075.md) | [79.8](/filings/0001921963-25-000121.md) | [63.2](/filings/0001921963-25-000134.md) | [54.6 d](/filings/0001921963-26-000015.md) | [64.9](/filings/0001921963-26-000042.md) | [81.7](/filings/0001921963-26-000069.md) | [81.9](/filings/0001921963-25-000134.md) | [70.5 d](/filings/0001921963-26-000015.md) | [76.3](/filings/0001921963-26-000042.md) | [97.2](/filings/0001921963-26-000069.md) | | Interest expense | $m | [11.0](/filings/0001921963-24-000118.md) | [10.6 d](/filings/0001921963-24-000007.md) | [10.5](/filings/0001921963-24-000074.md) | [10.5](/filings/0001921963-24-000098.md) | [10.4](/filings/0001921963-24-000118.md) | [9.2 d](/filings/0001921963-26-000015.md) | [8.4](/filings/0001921963-26-000042.md) | [8.5](/filings/0001921963-26-000069.md) | [8.5](/filings/0001921963-25-000134.md) | [8.0 d](/filings/0001921963-26-000015.md) | [14.1](/filings/0001921963-26-000042.md) | [13.7](/filings/0001921963-26-000069.md) | | Income tax | $m | [11.3](/filings/0001921963-24-000118.md) | [12.4 d](/filings/0001921963-26-000015.md) | [12.8](/filings/0001921963-25-000075.md) | [15.7](/filings/0001921963-25-000121.md) | [9.9](/filings/0001921963-25-000134.md) | [10.8 d](/filings/0001921963-26-000015.md) | [12.1](/filings/0001921963-26-000042.md) | [16.8](/filings/0001921963-26-000069.md) | [16.9](/filings/0001921963-25-000134.md) | [13.0 d](/filings/0001921963-26-000015.md) | [12.8](/filings/0001921963-26-000042.md) | [18.9](/filings/0001921963-26-000069.md) | | Net income | $m | [37.6](/filings/0001921963-24-000118.md) | [34.8 d](/filings/0001921963-26-000015.md) | [45.5](/filings/0001921963-25-000075.md) | [56.2](/filings/0001921963-25-000121.md) | [43.8](/filings/0001921963-25-000134.md) | [40.1 d](/filings/0001921963-26-000015.md) | [44.7](/filings/0001921963-26-000042.md) | [59.9](/filings/0001921963-26-000069.md) | [54.8](/filings/0001921963-25-000134.md) | [48.0 d](/filings/0001921963-26-000015.md) | [48.4](/filings/0001921963-26-000042.md) | [63.9](/filings/0001921963-26-000069.md) | | Diluted EPS | $ per share | [0.45](/filings/0001921963-24-000118.md) | not reported | [0.54](/filings/0001921963-25-000075.md) | [0.67](/filings/0001921963-25-000121.md) | [0.52](/filings/0001921963-25-000134.md) | not reported | [0.54](/filings/0001921963-26-000042.md) | [0.72](/filings/0001921963-26-000069.md) | [0.66](/filings/0001921963-25-000134.md) | not reported | [0.59](/filings/0001921963-26-000042.md) | [0.78](/filings/0001921963-26-000069.md) | | Basic EPS | $ per share | [0.45](/filings/0001921963-24-000118.md) | not reported | [0.55](/filings/0001921963-25-000075.md) | [0.67](/filings/0001921963-25-000121.md) | [0.53](/filings/0001921963-25-000134.md) | not reported | [0.54](/filings/0001921963-26-000042.md) | [0.73](/filings/0001921963-26-000069.md) | [0.67](/filings/0001921963-25-000134.md) | not reported | [0.59](/filings/0001921963-26-000042.md) | [0.78](/filings/0001921963-26-000069.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [139](/filings/0001921963-23-000025.md) | [168](/filings/0001921963-25-000029.md) | [149](/filings/0001921963-24-000074.md) | [161](/filings/0001921963-24-000098.md) | [197](/filings/0001921963-24-000118.md) | [184](/filings/0001921963-26-000015.md) | [183](/filings/0001921963-25-000075.md) | [191](/filings/0001921963-25-000121.md) | [218](/filings/0001921963-25-000134.md) | [236](/filings/0001921963-26-000069.md) | [210](/filings/0001921963-26-000042.md) | [259](/filings/0001921963-26-000069.md) | | Current assets | $m | [654](/filings/0001921963-23-000025.md) | [693](/filings/0001921963-25-000029.md) | [699](/filings/0001921963-24-000074.md) | [755](/filings/0001921963-24-000098.md) | [779](/filings/0001921963-24-000118.md) | [755](/filings/0001921963-26-000015.md) | [783](/filings/0001921963-25-000075.md) | [856](/filings/0001921963-25-000121.md) | [884](/filings/0001921963-25-000134.md) | [892](/filings/0001921963-26-000069.md) | [911](/filings/0001921963-26-000042.md) | [965](/filings/0001921963-26-000069.md) | | Total assets | $m | [1,026](/filings/0001921963-23-000025.md) | [1,089](/filings/0001921963-25-000029.md) | [1,104](/filings/0001921963-24-000074.md) | [1,177](/filings/0001921963-24-000098.md) | [1,218](/filings/0001921963-24-000118.md) | [1,190](/filings/0001921963-26-000015.md) | [1,228](/filings/0001921963-26-000042.md) | [1,314](/filings/0001921963-26-000069.md) | [1,339](/filings/0001921963-25-000134.md) | [1,351](/filings/0001921963-26-000069.md) | [1,842](/filings/0001921963-26-000042.md) | [1,890](/filings/0001921963-26-000069.md) | | Current liabilities | $m | [354](/filings/0001921963-23-000025.md) | [375](/filings/0001921963-25-000029.md) | [349](/filings/0001921963-24-000074.md) | [365](/filings/0001921963-24-000098.md) | [368](/filings/0001921963-24-000118.md) | [345](/filings/0001921963-26-000015.md) | [352](/filings/0001921963-25-000075.md) | [399](/filings/0001921963-25-000121.md) | [413](/filings/0001921963-25-000134.md) | [368](/filings/0001921963-26-000069.md) | [361](/filings/0001921963-26-000042.md) | [364](/filings/0001921963-26-000069.md) | | Total liabilities | $m | [992](/filings/0001921963-23-000025.md) | [1,008](/filings/0001921963-25-000029.md) | [982](/filings/0001921963-24-000074.md) | [999](/filings/0001921963-24-000098.md) | [997](/filings/0001921963-24-000118.md) | [963](/filings/0001921963-26-000015.md) | [963](/filings/0001921963-25-000075.md) | [998](/filings/0001921963-25-000121.md) | [1,002](/filings/0001921963-25-000134.md) | [972](/filings/0001921963-26-000069.md) | [1,438](/filings/0001921963-26-000042.md) | [1,436](/filings/0001921963-26-000069.md) | | Long-term debt | $m | [596](/filings/0001921963-23-000025.md) | [593](/filings/0001921963-25-000029.md) | [589](/filings/0001921963-24-000074.md) | [585](/filings/0001921963-24-000098.md) | [578](/filings/0001921963-24-000118.md) | [570](/filings/0001921963-26-000015.md) | [563](/filings/0001921963-25-000075.md) | [555](/filings/0001921963-25-000121.md) | [548](/filings/0001921963-25-000134.md) | [540](/filings/0001921963-26-000069.md) | [998](/filings/0001921963-26-000042.md) | [992](/filings/0001921963-26-000069.md) | | Current portion of debt | $m | [3.7](/filings/0001921963-23-000025.md) | [7.5](/filings/0001921963-25-000029.md) | [11.2](/filings/0001921963-24-000074.md) | [15.0](/filings/0001921963-24-000098.md) | [18.8](/filings/0001921963-24-000118.md) | [22.5](/filings/0001921963-26-000015.md) | [26.3](/filings/0001921963-25-000075.md) | [30.0](/filings/0001921963-25-000121.md) | [30.0](/filings/0001921963-25-000134.md) | [30.0](/filings/0001921963-26-000069.md) | [0.0](/filings/0001921963-26-000042.md) | [6.3](/filings/0001921963-26-000069.md) | | Shareholders' equity | $m | [34.4](/filings/0001921963-24-000118.md) | [80.7](/filings/0001921963-26-000015.md) | [122](/filings/0001921963-25-000121.md) | [178](/filings/0001921963-25-000134.md) | [221](/filings/0001921963-25-000134.md) | [227](/filings/0001921963-26-000069.md) | [265](/filings/0001921963-26-000069.md) | [316](/filings/0001921963-26-000069.md) | [337](/filings/0001921963-25-000134.md) | [379](/filings/0001921963-26-000069.md) | [404](/filings/0001921963-26-000069.md) | [455](/filings/0001921963-26-000069.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [58.3 d](/filings/0001921963-24-000118.md) | [41.7 d](/filings/0001921963-26-000015.md) | [(8.2)](/filings/0001921963-25-000075.md) | [22.9 d](/filings/0001921963-25-000121.md) | [70.7 d](/filings/0001921963-25-000134.md) | [20.0 d](/filings/0001921963-26-000015.md) | [28.7](/filings/0001921963-26-000042.md) | [44.4 d](/filings/0001921963-26-000069.md) | [82.1 d](/filings/0001921963-25-000134.md) | [47.5 d](/filings/0001921963-26-000015.md) | [38.1](/filings/0001921963-26-000042.md) | [77.8 d](/filings/0001921963-26-000069.md) | | Capital expenditure | $m | [10.5 d](/filings/0001921963-24-000118.md) | [16.2 d](/filings/0001921963-26-000015.md) | [10.6](/filings/0001921963-25-000075.md) | [11.6 d](/filings/0001921963-25-000121.md) | [16.4 d](/filings/0001921963-25-000134.md) | [10.0 d](/filings/0001921963-26-000015.md) | [12.4](/filings/0001921963-26-000042.md) | [12.0 d](/filings/0001921963-26-000069.md) | [13.2 d](/filings/0001921963-25-000134.md) | [16.3 d](/filings/0001921963-26-000015.md) | [12.6](/filings/0001921963-26-000042.md) | [13.0 d](/filings/0001921963-26-000069.md) | | Share repurchases | $m | not reported | [0.0 d](/filings/0001921963-26-000015.md) | [0.0](/filings/0001921963-25-000075.md) | [0.0 d](/filings/0001921963-25-000121.md) | [10.0 d](/filings/0001921963-25-000134.md) | [10.0 d](/filings/0001921963-26-000015.md) | [10.0](/filings/0001921963-26-000042.md) | [20.1 d](/filings/0001921963-26-000069.md) | [29.7 d](/filings/0001921963-25-000134.md) | [0.9 d](/filings/0001921963-26-000015.md) | [7.3](/filings/0001921963-26-000042.md) | [13.0 d](/filings/0001921963-26-000069.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [83.3](/filings/0001921963-23-000025.md) | [83.3](/filings/0001921963-24-000074.md) | [83.3](/filings/0001921963-24-000098.md) | [83.4](/filings/0001921963-24-000118.md) | [83.6](/filings/0001921963-25-000075.md) | [83.7](/filings/0001921963-25-000121.md) | [83.6](/filings/0001921963-25-000134.md) | [83.2](/filings/0001921963-26-000042.md) | [83.0](/filings/0001921963-26-000069.md) | [82.7](/filings/0001921963-25-000134.md) | [82.0](/filings/0001921963-26-000042.md) | [82.0](/filings/0001921963-26-000069.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 81,595,527 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001921963-26-000069.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.